Browsing by Author "Ferreira, D.C."
Now showing 1 - 3 of 3
Results Per Page
Sort Options
- Advances in nanoparticulate carriers for oral peptides and proteins: polymeric vs. lipid nanoparticlesPublication . Silva, Ana Catarina; Santos, D.; Ferreira, D.C.; Souto, Eliana B.
- Improving oral absorption of samon calcitonin by trimyristin lipid nanoparticlesPublication . Martins, S.; Silva, Ana Catarina; Ferreira, D.C.; Souto, Eliana B.Solid lipid nanoparticles (SLN) composed of trimyristin (solid lipid) and poloxamer 407 (surfactant) were prepared by a w/o/w emulsion technique for the incorporation of Salmon calcitonin, and further explored as protein carriers for oral delivery. Trimyristin SLN showed a mean size diameter of 200 nm with an association efficiency for calcitonin of approx. 86%. The morphology of SLN was investigated by cryo-SEM and by AFM, revealing spheroid shape SLN with a smooth surface. The in vitro release of calcitonin occurred for a period of 8 h, under both gastric and intestinal simulated pH conditions, predicting suitable properties for oral administration. The pharmacological activity of the protein was evaluated following oral dosage of calcitonin-loaded SLN in rats. SLN lowered the basal blood calcium levels by up to 20% with 500 IU/kg dose sustaining hypocalcaemia over 8 h. The results indicate that incorporation of Salmon calcitonin into trimyristin SLN is a key factor for the improvement of the efficiency of such carriers for oral delivery of proteins.
- Sustained drug release by contact lenses for glaucoma treatment - a reviewPublication . Carvalho, I.M.; Marques, C.S.; Oliveira, Rita; Barata, Pedro; Costa, P.C.; Ferreira, D.C.In the context of ocular pharmacology, there is a growing need for innovative delivery platforms for a convenient and sustained drug release into the eye, especially for chronic diseases that require the adoption of a strict insurmountable treatment regimen for a large part of the affected population, as in the case of glaucoma. Due to the large residence time of the contact lenses in the eye, its use for sustained drug delivery is quite promising. However, and despite the numerous therapeutic advantages arising from its use, the low affinity shown by most ophthalmic drugs for conventional contact lenses hinders the practical application of this technology. In this paper we elaborated a review of the various methods exploited so far to improve the contact lenses' characteristics as mechanisms for controlled and prolonged drug release for topical treatment of ocular diseases, with particular emphasis on the treatment of glaucoma.